We came across a bullish thesis on Edwards Lifesciences Corporation (EW) on Substack by Natan. In this article, we will ...

Edwards Lifesciences Corp ... Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio ...

Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business ...

Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.

So much in life is determined by being in the right place at the right time, and by being prepared and bold enough to seize opportunities as they present themselves. I was prepared in large part ...

Edwards Lifesciences stock lost almost a third of its value Thursday, undercutting the lower boundary of its base, after the medtech giant slashed its outlook for some heart-valve replacements ...

In the latest quarter, 11 analysts provided ratings for Edwards Lifesciences EW, showcasing a mix of bullish and bearish ...

Favorable hospitalization trend, strong adoption of transcatheter heart valves and improved procedural volume are expected to have aided EW in the fourth quarter.

Starr persuaded Edwards to first collaborate on the design for an artificial heart valve, Kaul said. "An avid inventor with many patents, Edwards wanted to apply his knowledge of hydraulics ...

Richard Mullins. “The two had a conversation.” Starr convinced Edwards they needed a successful artificial heart valve first and they agreed to embark on an ambitious project, each offering ...